Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors

31 Oct 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37981443
DOI: 10.1016/j.ejmech.2023.115923

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitorsPMID 37981443Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read ↗

Discovering small-molecule therapeutics against SARS-CoV-2Semantic proximity Read ↗

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read ↗

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host CellsSemantic proximity Read ↗

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sitesSemantic proximity Read ↗

Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discoverySemantic proximity Read ↗

Structural biology of SARS-CoV-2 and implications for therapeutic developmentSemantic proximity Read ↗

SARS-CoV-2 biology and host interactionsSemantic proximity Read ↗

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorSemantic proximity Read ↗

Potential drug targets of SARS-CoV-2: From genomics to therapeuticsSemantic proximity Read ↗

Structural and molecular perspectives of SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.